|
ME2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.832000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.662000E-01 |
| Normal-vs-Stage2 |
9.319800E-02 |
| Normal-vs-Stage3 |
7.849600E-01 |
| Normal-vs-Stage4 |
6.378200E-01 |
| Stage1-vs-Stage2 |
1.292980E-01 |
| Stage1-vs-Stage3 |
5.249600E-01 |
| Stage1-vs-Stage4 |
8.308400E-01 |
| Stage2-vs-Stage3 |
5.933500E-02 |
| Stage2-vs-Stage4 |
2.052400E-01 |
| Stage3-vs-Stage4 |
5.251000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.214800E-01 |
| Normal-vs-AfricanAmerican |
5.547600E-02 |
| Normal-vs-Asian |
4.617600E-01 |
| Caucasian-vs-AfricanAmerican |
6.176600E-03 |
| Caucasian-vs-Asian |
5.518800E-01 |
| AfricanAmerican-vs-Asian |
8.851800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.482800E-01 |
| Normal-vs-Female |
7.683200E-01 |
| Male-vs-Female |
1.292370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.145200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.554200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.081600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.224400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.913200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.351400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.834400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.801200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.552400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.217000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.972560E-01 |
| Normal-vs-Grade 2 |
3.742800E-01 |
| Normal-vs-Grade 3 |
7.233400E-01 |
| Normal-vs-Grade 4 |
5.933000E-01 |
| Grade 1-vs-Grade 2 |
9.220300E-02 |
| Grade 1-vs-Grade 3 |
2.786200E-01 |
| Grade 1-vs-Grade 4 |
1.556410E-01 |
| Grade 2-vs-Grade 3 |
5.474400E-01 |
| Grade 2-vs-Grade 4 |
9.594000E-01 |
| Grade 3-vs-Grade 4 |
7.413800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.297200E-01 |
| Normal-vs-ccB subtype |
4.225600E-01 |
| ccA subtype-vs-ccB subtype |
7.700800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.192600E-01 |
| Normal-vs-N1 |
9.224200E-02 |
| N0-vs-N1 |
1.198440E-01 |
|
|
